Novartis AG (NVSEF)
134.75
-3.02
(-2.19%)
USD |
OTCM |
Sep 14, 16:00
Novartis Price : 134.75 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | 137.25 | 137.41 | 134.75 | 134.75 | 2908.00 |
| Sep 11, 2026 | 137.76 | 137.76 | 137.76 | 137.76 | 300459.0 |
| Sep 10, 2026 | 137.38 | 137.95 | 137.38 | 137.95 | 898.00 |
| Sep 09, 2026 | 138.50 | 138.50 | 138.50 | 138.50 | 339.00 |
| Sep 08, 2026 | 164.25 | 164.25 | 164.25 | 164.25 | 39152.00 |
| Sep 04, 2026 | 164.25 | 164.25 | 164.25 | 164.25 | 114.00 |
| Sep 03, 2026 | 164.25 | 164.25 | 164.25 | 164.25 | 3983.00 |
| Sep 02, 2026 | 156.80 | 156.80 | 156.80 | 156.80 | 236.00 |
| Sep 01, 2026 | 158.07 | 164.62 | 158.07 | 162.10 | 802.00 |
| Aug 31, 2026 | 145.01 | 145.01 | 145.01 | 145.01 | 385.00 |
| Aug 28, 2026 | 163.60 | 163.60 | 163.60 | 163.60 | 1346.00 |
| Aug 27, 2026 | 163.60 | 163.60 | 163.60 | 163.60 | 295.00 |
| Aug 26, 2026 | 163.60 | 163.60 | 163.60 | 163.60 | 59.00 |
| Aug 25, 2026 | 163.60 | 163.60 | 163.60 | 163.60 | 36050.00 |
| Aug 24, 2026 | 160.24 | 163.60 | 160.24 | 163.60 | 533.00 |
| Aug 21, 2026 | 157.61 | 157.61 | 157.61 | 157.61 | 62.00 |
| Aug 20, 2026 | 157.61 | 157.61 | 157.61 | 157.61 | 380.00 |
| Aug 19, 2026 | 160.00 | 160.00 | 160.00 | 160.00 | 2294.00 |
| Aug 18, 2026 | 149.73 | 149.73 | 149.73 | 149.73 | 169.00 |
| Aug 17, 2026 | 149.28 | 149.28 | 145.93 | 145.93 | 857.00 |
| Aug 14, 2026 | 157.90 | 157.90 | 157.90 | 157.90 | 89.00 |
| Aug 13, 2026 | 157.90 | 157.90 | 157.90 | 157.90 | 131.00 |
| Aug 12, 2026 | 157.90 | 157.90 | 157.90 | 157.90 | 146.00 |
| Aug 11, 2026 | 157.00 | 157.90 | 157.00 | 157.90 | 374.00 |
| Aug 10, 2026 | 151.42 | 151.42 | 151.42 | 151.42 | 4629.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Roche Holding AG | 54.80 |
| Addex Therapeutics Ltd. | 3.26 |
| Oculis Holding AG | 10.07 |
| Sandoz Group AG | 81.32 |
| Galderma Group AG | 38.01 |
Price Related Metrics
| PE Ratio | 20.34 |
| PS Ratio | 4.736 |
| Price to Book Value | 5.938 |
| Price to Free Cash Flow | 17.09 |
| Earnings Yield | 4.92% |
| Market Cap | 246.67B |
| Operating PE Ratio | 16.01 |
| Normalized PE Ratio | 18.95 |